The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was 100 times better after they received gene therapy to address the genetic ...
CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely vision-impaired and blind patients, a randomized clinical trial showed. After ...
Bothnia dystrophy is a form of hereditary blindness, prevalent in the region Västerbotten in Sweden. A new study at Karolinska Institutet published in Nature Communications shows that gene therapy can ...
(CNN) — For her entire life, college student Olivia Cook had only a small degree of central vision. It was as if she was watching the world through a straw hole, and in dimly lit places, she could not ...
Please provide your email address to receive an email when new articles are posted on . MCO-010, a mutation-agnostic gene therapy, demonstrated vision improvement in retinitis pigmentosa. Nanoscope ...
Please provide your email address to receive an email when new articles are posted on . Optometrists sometimes suggest vision therapy to improve visual skills, addressing perceptual vision and myopia.
Age-related macular degeneration (AMD) gradually affects central vision in one or both eyes while leaving peripheral vision (on the sides) intact. This peripheral vision – encompassing everything you ...
Gene therapy may restore vision to children and adults robbed of their sight by a rare inherited condition called Leber congenital amaurosis, researchers report. The illness is caused by mutations in ...
Medical Device Network on MSN
Myra Vision enrols first patient in trial of Calibreye glaucoma system
The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.
Scientists in the UK have successfully used gene therapy to restore some vision to legally blind children with an inherited retinal condition. All 11 children in the clinical trial saw improvements ...
Myra Vision has treated the first patient in its ADAPT clinical study evaluating the Calibreye TGT Surgical System in ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果